Regeneron stops enrolling critically ill COVID-19 patients for antibody drug trial | TheHill The HillView Full Coverage on Google News

BING NEWS:
  • IMNN: IND Application Submitted for Phase 1/2 Trial of Seasonal COVID-19 Vaccine…
    IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Update on IMNN-101 Imunon, Inc. (NASDAQ:IMNN) is developing IMNN-101, which is a COVID-19 seasonal vaccine booster based on the company’s ...
    04/12/2024 - 3:41 am | View Link
  • FDA rejects Regeneron lymphoma drug, setting back company’s oncology push
    The Food and Drug Administration declined to approve an experimental lymphoma drug from Regeneron Pharmaceuticals, asking the company to first make more progress with a trial meant to confirm ...
    03/24/2024 - 1:00 pm | View Link
  • Regeneron's antibody cocktail effective in preventing COVID-19 infection: study
    (Reuters) - Regeneron Pharmaceuticals Inc said on Tuesday its antibody cocktail was effective in preventing COVID-19 ... trial is expected early in the second quarter The U.S. Food and Drug ...
    01/25/2021 - 11:55 pm | View Link
  • Regeneron Covid Drug Gets Emergency OK
    Antibody drug ... trial of patients infected with the coronavirus showed that casirivimab and imdevimab, when given together and administered via intravenous infusion, cut down Covid-19-related ...
    11/22/2020 - 7:21 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More World News